<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4(5)</volume><submitter>Watanabe A</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Evidence is limited regarding the comparative effectiveness and safety of mechanical thrombectomy (MT) vs catheter-directed thrombolysis (CDT) for high-risk pulmonary embolism (PE).&lt;h4>Objectives&lt;/h4>This observational study aimed to compare the outcomes of older adults with high-risk PE treated with MT vs CDT using a target trial emulation framework.&lt;h4>Methods&lt;/h4>We included Medicare fee-for-service beneficiaries aged 65 to 99 years admitted with high-risk PE (defined by cardiac arrest, shock, and vasopressor use) who underwent MT/CDT from 2017 to 2020. We evaluated 1-year mortality using an inverse probability of treatment weighting approach, controlling for 62 baseline covariates. We also evaluated readmissions and in-hospital outcomes, including intracranial hemorr</pubmed_abstract><journal>JACC. Advances</journal><pagination>101706</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12018976</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Mechanical Thrombectomy vs Catheter-Directed Thrombolysis for High-Risk Pulmonary Embolism: A Target Trial Emulation.</pubmed_title><pmcid>PMC12018976</pmcid><pubmed_authors>Kuno T</pubmed_authors><pubmed_authors>Tsugawa Y</pubmed_authors><pubmed_authors>Bangalore S</pubmed_authors><pubmed_authors>Ueyama HA</pubmed_authors><pubmed_authors>Watanabe A</pubmed_authors><pubmed_authors>Miyamoto Y</pubmed_authors><pubmed_authors>Gotanda H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mechanical Thrombectomy vs Catheter-Directed Thrombolysis for High-Risk Pulmonary Embolism: A Target Trial Emulation.</name><description>&lt;h4>Background&lt;/h4>Evidence is limited regarding the comparative effectiveness and safety of mechanical thrombectomy (MT) vs catheter-directed thrombolysis (CDT) for high-risk pulmonary embolism (PE).&lt;h4>Objectives&lt;/h4>This observational study aimed to compare the outcomes of older adults with high-risk PE treated with MT vs CDT using a target trial emulation framework.&lt;h4>Methods&lt;/h4>We included Medicare fee-for-service beneficiaries aged 65 to 99 years admitted with high-risk PE (defined by cardiac arrest, shock, and vasopressor use) who underwent MT/CDT from 2017 to 2020. We evaluated 1-year mortality using an inverse probability of treatment weighting approach, controlling for 62 baseline covariates. We also evaluated readmissions and in-hospital outcomes, including intracranial hemorr</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-07-06T03:04:12.61Z</modification><creation>2025-07-06T03:04:12.61Z</creation></dates><accession>S-EPMC12018976</accession><cross_references><pubmed>40286366</pubmed><doi>10.1016/j.jacadv.2025.101706</doi></cross_references></HashMap>